This site is intended only for healthcare professionals resident in the United Kingdom

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Information on how to access prescribing information and adverse event reporting can be found at the bottom of the page.

These videos show experts presenting their clinical experience of managing CAP and cSSTIs. Watch to find out more about Zinforo®.

Dr Silvia Corcione

Appropriate management of cSSTI and CAP infection.

Professor Antoni Torres:

Challenges in the treatment of CAP (presentation-style)​​​

Professor Antoni Torres:

Challenges in the treatment of CAP (interview-style)​​​​​

Dr Matthew Dryden:

Considerations in the treatment of cSSTI and CAP (presented at EAHP)

Dr Matthew Dryden:

Understanding the management of critically ill patients (presented at EAHP)

Professor Tobias Welte:

Managing community-acquired pneumonia (CAP) in clinical practice: a case-led discussion​
​​​​​

Explore More

Resources

Access our resources for implementation of an Antimicrobial Stewardship Programme and learn more about Pfizer initiatives to fight antimicrobial resistance

Access AMS Resources

SMART Hub

Access real-time stock monitoring, helpful information and videos about our supply chain, plus a range of training resources.

Access SMART Hub
Abbreviations
​​​​​​​
CAP, community-acquired pneumonia; cSSTI, complicated skin and soft tissue infections

Prescribing Information
​​​​​​​
Zinforo® (ceftaroline fosamil)
Great Britain
Zinforo 600 mg powder for concentrate for solution for infusion
Northern Ireland
Zinforo 600 mg powder for concentrate for solution for infusion 


Zyvox® (linezolid) 2 mg/ml solution for infusion
Zyvox ® (linezolid) 100 mg/5 ml granules for oral suspension
Zyvox ® (linezolid) 600 mg film-coated tablets

Tazocin® (piperacillin sodium, tazobactam sodium) 2g/0.25g Powder for Solution for Infusion
Tazocin® (piperacillin sodium, tazobactam sodium) 4g/0.5g Powder for Solution for Infusion

Tygacil (tigecycline) 50mg powder for solution for infusion​​​​​​​

Meronem (meropenem trihydrate)  -  IV 1g
Meronem (meropenem trihydrate)  -  IV 500mg


Dalacin C (clindamycin hydrochloride) 150mg capsules
Dalacin C (clindamycin hydrochloride) 75mg capsules
Dalacin C (clindamycin phosphate)  sterile solution for injection
Dalacin T (clindamycin phosphate) 1% topical lotion
Dalacin (clindamycin phosphate) 2% cream

Zithromax (azithromycin dihydrate) 250 mg capsules

Zithromax (azithromycin dihydrate) 200mg/5ml oral suspension

​​​​​​​
Gentamicin (gentamicin sulfate) 40 mg/ml Injection
Legal Category: Prescription Only Medicine (POM)
NHS Price: 5 vial £20.00 
Click here for the Summary of Product Characteristics

Ciprofloxacin (ciprofloxacin lactate) 2 mg/ml Solution for Infusion
Legal Category: Prescription Only Medicine (POM)
NHS Price: 10 bag £200.00 
Click here for the Summary of Product Characteristics

PP-ZFO-GBR-0234. September 2021

Join us!

Follow the link to learn about out upcoming meetings and online webinar events - dates, location and agendas.

Register here

Tolerability profile of Zinforo

Access data on the tolerability profile of Zinforo as established in key Phase III clinical trials 

View tolerability profile 

** This is an optional area where footnotes can live.

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-2688. December 2020

Yes

No